LAURYN LESLIE: Open Payments
NPI 1194288266 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,068 in 131 payments from 19 companies in 2025. Trend: 2023 $1,113 · 2024 $1,208 · 2025 $3,068
Food & beverage: $3,068
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $623 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $328 |
| GlaxoSmithKline, LLC. | 17 | $293 |
| GENZYME CORPORATION | 10 | $220 |
| Grifols USA, LLC | 12 | $218 |
| Regeneron Healthcare Solutions, Inc. | 4 | $194 |
| Viatris Specialty LLC | 8 | $180 |
| Verona Pharma, Inc. | 8 | $174 |
| Merck Sharp & Dohme LLC | 9 | $171 |
| ANI Pharmaceuticals, Inc. | 6 | $153 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, BREZTRI, Prolastin-C Liquid, YUPELRI, Ohtuvayre, PURIFIED CORTROPHIN GEL.
Industry payments across LA — which companies pay providers there.
